Elevated low-density lipoprotein cholesterol (LDL-C) level is associated with an increased
risk of atherosclerotic cardiovascular disease. Although high-intensity lipid-lowering …

Coronary artery disease continues to be the leading cause of death globally. Identifying
patients who are at risk of coronary artery disease remains a public health priority. At …

Objective: Statin treatment reduces the risk of atherosclerotic cardiovascular disease but is
associated with a modest increased risk of type 2 diabetes, especially in those with insulin …

Background Inclisiran is a novel, cholesterol-lowering therapy, with a long duration of effect,
administered every 6 months (subcutaneously by a healthcare professional). In the ORION …

Importance Statins are prescribed to help lower cholesterol levels but have poor adherence
rates. Attitudes or beliefs toward medications are important to ascertain because they may …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing
approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the …

Benefits and safety on statins have been well-established over 20 years of research. Despite
this, the vast majority of patients are not adequately treated and do not achieve the low …

Objective Lack of adherence to treatment is frequent in chronic inflammatory rheumatic
diseases and is associated with poorer outcomes. The objective of this study was to …

Background Adherence to treatment is a key issue in chronic inflammatory rheumatic
diseases (CIRDs). Objective To develop recommendations to facilitate in daily practice, the …

Objective To assess adherence to lipid lowering therapy (LLT), reasons for poor adherence,
and achievement of LDL-C treatment goals in children and young adults with familial …